Roy S. Herbst, MD, PhD, on Lung Cancer: Update on Immunotherapy
Posted: Sunday, January 28, 2018
Roy S. Herbst, MD, PhD, of the Yale School of Medicine, discusses effective combination therapies and why some tumors are resistant to immunotherapy.
Non–Small Cell Lung Cancer Coverage from Every Angle
